Search results
Ozempic lead counsel selection process is model for judges in big cases
Reuters· 2 hours ago, opens new tab in consolidated litigation over allegedly undisclosed side effects from Ozempic and...
Judge Expands Ozempic Plaintiffs' Leadership Team, Names 4 Co-Lead Counsel | The Legal Intelligencer
Law.com· 18 hours agoThe four main contenders for roles as plaintiffs’ co-lead counsel in the Ozempic multidistrict...
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure ...
WFRV 5 Green Bay· 24 hours ago(NASDAQ: CKPT) between March 10, 2021 and December 15, 2023, both dates inclusive (the "Class Period"), of the important June 4, 2024 lead plaintiff deadline ...
District court judge declines to take immediate action in St. Isidore of Seville case
Gannett via AOL· 12 hours agoDuring arguments, Luchenitser suggested a temporary injunction could be narrowly tailored to prevent...
INVZ Investors Have Opportunity to Lead Innoviz Technologies Ltd. Securities Fraud Lawsuit
FOX 59 Indianapolis· 1 day agoClass Period: April 21, 2021 – February 28, 2023Lead Plaintiff Deadline: May 14, 2024 If you wish to...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 hours agoRADNOR, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) (“GoodRx” or the